Increasing HDL cholesterol
Pro Research Analysisby 
Searched over 200M research papers
HDL Cholesterol and Cardiovascular Disease Risk
High-density lipoprotein (HDL) cholesterol is widely recognized for its protective role against cardiovascular disease. HDL helps remove excess cholesterol from peripheral tissues and transports it to the liver for excretion, a process known as reverse cholesterol transport. This function is believed to reduce the risk of atherosclerosis and related cardiovascular events 128.
Strategies for Increasing HDL Cholesterol
Pharmacological Approaches
Several drug classes have been developed to increase HDL cholesterol, including statins, fibrates, niacin, and cholesteryl ester transfer protein (CETP) inhibitors. While these drugs can raise HDL cholesterol levels, clinical trials have shown mixed results regarding their effectiveness in reducing cardiovascular events. For example, CETP inhibitors like torcetrapib, dalcetrapib, and evacetrapib increased HDL cholesterol but did not consistently lower cardiovascular risk, possibly due to off-target effects or insufficient trial duration. However, anacetrapib, another CETP inhibitor, showed a modest reduction in major coronary events, though it remains unclear if this benefit was due to HDL increase or other lipid changes 3710.
Focus on HDL Functionality
Recent research suggests that simply increasing HDL cholesterol levels may not be enough to reduce cardiovascular risk. The functionality of HDL particles—such as their ability to promote cholesterol efflux, reduce inflammation, and provide antioxidant effects—may be more important than the absolute HDL cholesterol concentration. Therapeutic strategies are now considering ways to improve HDL function or target specific HDL subclasses, such as HDL3, which may offer better protective effects than others 24510.
Dietary and Lifestyle Factors
Diet and lifestyle can influence HDL cholesterol levels. In animal studies, a high-fat/high-cholesterol diet increased serum apoE-rich HDL and upregulated hepatic ABCA1 expression, which is involved in cholesterol efflux. However, in large population studies, such as those conducted in Japan, the steady increase in HDL cholesterol over decades could not be fully explained by changes in diet, physical activity, or other lifestyle factors, suggesting that other, yet unidentified, influences may be at play 69.
Challenges and Future Directions
Despite the clear association between higher HDL cholesterol and lower cardiovascular risk, increasing HDL cholesterol through medication has not always translated into better clinical outcomes. This has led to a shift in focus from raising HDL cholesterol levels to enhancing HDL particle functionality and targeting specific HDL subpopulations. Ongoing research aims to better understand the complex biology of HDL and to develop more effective therapies for cardiovascular risk reduction 2457+1 MORE.
Conclusion
While increasing HDL cholesterol remains a promising strategy for cardiovascular disease prevention, current evidence suggests that improving HDL function and targeting specific HDL subclasses may be more effective than simply raising HDL cholesterol levels. Future therapies will likely focus on these aspects to achieve better cardiovascular outcomes.
Sources and full results
Most relevant research papers on this topic